DNB Carnegie | Back Bay Partnership

Strategic advice based on nuanced understanding of the clinical and scientific foundations of new therapeutics and medical technologies, expertise in business and financial markets, and knowledge of what makes successful R&D, commercialization and transactions. The Partnership provides actionable strategies for product development, commercial success and transactional execution to drive growth and investment returns

Capital raising in global public and private equity markets, institutional sales and trading, and equity research

Read more about our ECM services

Structuring and marketing debt instruments such as loans, bonds, convertible bonds, direct lending and other private placements, including new issues, refinancings, and acquisition financing

Read more about our DCM services

International transaction execution experience across the full spectrum of licensing, partnering, mergers, acquisitions and divestitures

Read more about our M&A services

Access to the unparalleled resources of recognized leaders in global healthcare corporate development and financing. Team coverage across New York, Boston, Oslo, Copenhagen, Stockholm, Toronto, London, and Singapore

Contact information to our local teams

DNB Carnegie is the Nordic’s largest financial institution and leading corporate and investment bank, with international expertise in corporate banking and public capital markets across selected industry sectors, specializing in arranging financing for healthcare companies globally.

The DNB Group has been established in North America since 1975, with a full service branch in New York that serves corporate customers in the bank’s strategic business areas. A full range of investment banking services are provided by DNB Carnegie*.

*Securities products and services are offered in the U.S. through DNB Carnegie, Inc., a U.S. registered broker-dealer and a separately incorporated subsidiary of DNB Bank ASA. DNB Carnegie, Inc. is a member of the Financial Industry Regulatory Authority (“FINRA”) and the Securities Investor Protection Corporation (“SIPC”). Securities products and services are offered in the European Economic Area through DNB Carnegie, a division of DNB Bank ASA

Back Bay Life Science Advisors (Back Bay) provides life science strategy and investment banking guidance and execution to global life science companies and their investors. Back Bay’s integrated strategy and banking teams advise companies on all aspects of life science, healthcare technology and drug development, including planning an initial concept, product commercialization, franchise growth, licensing, partnering, M&A, divestiture and more. 

With a strong presence in Europe and the Nordic markets and a global reach, Back Bay has guided hundreds of healthcare companies through the complexities of commercial development and transactions. Every project and transaction is rooted in Back Bay’s deep expertise in life science, healthcare industry strategy and investment banking. Learn more:www.bblsa.com